Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–54.
Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology. 1991;23(2):118–24.
Barinas-Mitchell E, Cushman M, Meilahn EN, Tracy RP, Kuller LH. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women. Am J Epidemiol. 2001;153(11):1094–101.
Fransson EI, Batty GD, Tabak AG, Brunner EJ, Kumari M, Shipley MJ, Singh-Manoux A, Kivimaki M. Association between change in body composition and change in inflammatory markers: an 11-year follow-up in the Whitehall II Study. J Clin Endocrinol Metab. 2010;95(12):5370–4.
Nguyen XM, Lane J, Smith BR, Nguyen NT. Changes in inflammatory biomarkers across weight classes in a representative US population: a link between obesity and inflammation. J gastrointest surg. 2009;13(7):1205–12.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131–5.
Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96(9):939–49.
Shin D, Song WO. Prepregnancy body mass index is an independent risk factor for gestational hypertension, gestational diabetes, preterm labor, and small- and large-for-gestational-age infants. J Matern fetal Neonatal Med. 2015;28(14):1679–86.
Rosenberg TJ, Garbers S, Chavkin W, Chiasson MA. Prepregnancy weight and adverse perinatal outcomes in an ethnically diverse population. Obstet Gynecol. 2003;102(5 Pt 1):1022–7.
Schummers L, Hutcheon JA, Bodnar LM, Lieberman E, Himes KP. Risk of adverse pregnancy outcomes by prepregnancy body mass index: a population-based study to inform prepregnancy weight loss counseling. Obstet Gynecol. 2015;125(1):133–43.
Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2004;18(5):377–84.
Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care. 2003;26(3):819–24.
Rebelo F, Schlussel MM, Vaz JS, Franco-Sena AB, Pinto TJ, Bastos FI, Adegboye AR, Kac G. C-reactive protein and later preeclampsia: systematic review and meta-analysis taking into account the weight status. J Hypertens. 2013;31(1):16–26.
Shin D, Hur J, Cho EH, Chung HK, Shivappa N, Wirth MD, Hebert JR, Lee KW. Pre-Pregnancy Body Mass Index Is Associated with Dietary Inflammatory Index and C-Reactive Protein Concentrations during Pregnancy. Nutrients. 2017;9(4):351.
Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab. 2003;88(8):3507–12.
Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol. 2005;162(12):1198–206.
Witteveen AB, Henrichs J, Bellers M, van Oenen E, Verhoeven CJ, Vrijkotte TGM: Mediating role of C-reactive protein in associations between pre-pregnancy BMI and adverse maternal and neonatal outcomes: the ABCD-study cohort. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2022;35(15):2867–75.
Krukowski RA, Bursac Z, McGehee MA, West D. Exploring potential health disparities in excessive gestational weight gain. J Womens Health. 2013;22(6):494–500.
Restall A, Taylor RS, Thompson JM, Flower D, Dekker GA, Kenny LC, Poston L, McCowan LM. Risk factors for excessive gestational weight gain in a healthy, nulliparous cohort. J obes. 2014;2014:148391.
Garay SM, Sumption LA, Pearson RM, John RM. Risk factors for excessive gestational weight gain in a UK population: a biopsychosocial model approach. BMC Pregnancy Childbirth. 2021;21(1):43.
Heery E, Kelleher CC, Wall PG, McAuliffe FM. Prediction of gestational weight gain - a biopsychosocial model. Public Health Nutr. 2015;18(8):1488–98.
Kowal C, Kuk J, Tamim H. Characteristics of weight gain in pregnancy among Canadian women. Matern Child Health J. 2012;16(3):668–76.
Logan CA, Bornemann R, Koenig W, Reister F, Walter V, Fantuzzi G, Weyermann M, Brenner H, Genuneit J, Rothenbacher D. Gestational weight gain and fetal-maternal adiponectin, leptin, and CRP: results of two birth cohorts studies. Sci Rep. 2017;7:41847.
Perng W, Rifas-Shiman SL, Rich-Edwards JW, Stuebe AM, Oken E. Inflammation and weight gain in reproductive-aged women. Ann Hum Biol. 2016;43(1):91–5.
Hrolfsdottir L, Schalkwijk CG, Birgisdottir BE, Gunnarsdottir I, Maslova E, Granstrom C, Strom M, Olsen SF, Halldorsson TI. Maternal diet, gestational weight gain, and inflammatory markers during pregnancy. Obesity. 2016;24(10):2133–9.
Dhingra R, Gona P, Nam BH, D’Agostino RB Sr, Wilson PW, Benjamin EJ, O’Donnell CJ. C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med. 2007;120(12):1054–62.
Dinh KM, Kaspersen KA, Mikkelsen S, Pedersen OB, Petersen MS, Thorner LW, Hjalgrim H, Rostgaard K, Ullum H, Erikstrup C. Low-grade inflammation is negatively associated with physical health-related quality of Life in healthy individuals: results from the danish blood donor study (DBDS). PLoS ONE. 2019;14(3):e0214468.
Rifai N, Ridker PM. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem. 2003;49(4):666–9.
Imhof A, Frohlich M, Loewel H, Helbecque N, Woodward M, Amouyel P, Lowe GD, Koenig W. Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem. 2003;49(4):669–72.
Weight Gain During Pregnancy: Reexamining the Guidelines. Institute of Medicine (US) and National Research
Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines. Kathleen M Rasmussen, Ann L
Yaktine<br>, editors. Washington (DC): National Academies Press (US); 2009. https://pubmed.ncbi.nlm.nih.gov/20669500/.
Romero R, Gotsch F, Pineles B, Kusanovic JP. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev. 2007;65(12 Pt 2):S194-202.
Palm M, Axelsson O, Wernroth L, Larsson A, Basu S. Involvement of inflammation in normal pregnancy. Acta Obstet Gynecol Scand. 2013;92(5):601–5.
Cotechini T, Graham CH. Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target? Placenta. 2015;36(8):960–6.
Larsson A, Palm M, Hansson LO, Basu S, Axelsson O. Reference values for alpha1-acid glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet Gynecol Scand. 2008;87(10):1084–8.
Watts DH, Krohn MA, Wener MH, Eschenbach DA. C-reactive protein in normal pregnancy. Obstet Gynecol. 1991;77(2):176–80.
Friis CM, Paasche Roland MC, Godang K, Ueland T, Tanbo T, Bollerslev J, Henriksen T. Adiposity-related inflammation: effects of pregnancy. Obesity. 2013;21(1):E124-130.
Christian LM, Porter K. Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index. Cytokine. 2014;70(2):134–40.
Fujimori M, Franca EL, Morais TC, Fiorin V, de Abreu LC, Honorio-Franca AC. Cytokine and adipokine are biofactors can act in blood and colostrum of obese mothers. BioFactors. 2017;43(2):243–50.
Whitaker KM, Marino RC, Haapala JL, Foster L, Smith KD, Teague AM, Jacobs DR, Fontaine PL, McGovern PM, Schoenfuss TC, et al. Associations of Maternal Weight Status Before, During, and After Pregnancy with Inflammatory Markers in Breast Milk. Obesity. 2017;25(12):2092–9.
Saito I, Yonemasu K, Inami F. Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. Circ J. 2003;67(4):323–9.
Thompson AL, Koehler E, Herring AH, Paynter L, Du S, Zhang B, Popkin B, Gordon-Larsen P. Weight Gain Trajectories Associated With Elevated C-Reactive Protein Levels in Chinese Adults. J Am Heart Assoc. 2016;5(9):e003262.
Barzilay JI, Forsberg C, Heckbert SR, Cushman M, Newman AB. The association of markers of inflammation with weight change in older adults: the Cardiovascular Health Study. Int J Obes. 2006;30(9):1362–7.
Engstrom G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes. 2003;52(8):2097–101.
Holz T, Thorand B, Doring A, Schneider A, Meisinger C, Koenig W. Markers of inflammation and weight change in middle-aged adults: results from the prospective MONICA/KORA S3/F3 study. Obesity. 2010;18(12):2347–53.
Nazmi A, Victora CG. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health. 2007;7:212.
Hart MJ, Torres SJ, McNaughton SA, Milte CM. A Dietary Inflammatory Index and associations with C-reactive protein in a general adult population. Eur J Nutr. 2021;60(7):4093–106.
Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45(10):1563–9.
Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. N Engl J Med. 2005;352(15):1611–3.
Kushner I, Samols D, Magrey M. A unifying biologic explanation for “high-sensitivity” C-reactive protein and “low-grade” inflammation. Arthritis Care Res. 2010;62(4):442–6.